Gastric Cancer Diagnostic Procedure Global Market Report 2025

Description

The diagnostic procedure for gastric cancer involves the identification and treatment of cancerous cells in the stomach. This procedure is crucial for diagnosing stomach cancer.

Key procedures in the diagnostic process for gastric cancer include endoscopic procedures, biopsies, tissue tests, laboratory tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics, immunoassays, and others. The endoscopic procedure involves the examination of internal organs, such as the gastrointestinal tract, by inserting a long, thin tube directly into the body. This endoscopy procedure is utilized in gastric cancer diagnosis, addressing both symptomatic and asymptomatic cases, and encompasses instruments, reagents and consumables, and services. Various body fluids, including blood, urine, saliva, stomach juice, and tissue, are required for the procedure. These fluids aid in the detection and treatment of both early and advanced gastric cancer.

The gastric cancer diagnostic procedure market research report is one of a series of new reports from The Business Research Company that provides gastric cancer diagnostic procedure market statistics, including the gastric cancer diagnostic procedure industry's global market size, regional shares, competitors with a gastric cancer diagnostic procedure market share, detailed gastric cancer diagnostic procedure market segments, market trends, and opportunities, and any further data you may need to thrive in the gastric cancer diagnostic procedure industry. This gastric cancer diagnostic procedure market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gastric cancer diagnostic procedure market size has grown strongly in recent years. It will grow from $1.44 billion in 2024 to $1.54 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to innovations in biopsy techniques, increased research funding, evolution of biomarker discovery, improved pathological analysis, shifts in screening guidelines

The gastric cancer diagnostic procedure market size is expected to see strong growth in the next few years. It will grow to $2.07 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to rise in point-of-care testing, introduction of novel biomarkers, shift towards personalized medicine, adoption of next-generation sequencing, enhanced endoscopic imaging modalities. Major trends in the forecast period include integration of nanotechnology, adoption of big data analytics, application of microbiota analysis, increased patient-centric approaches, role of telehealth in diagnostics.

The increasing prevalence of gastrointestinal diseases is a driving force behind the anticipated growth in the gastric cancer diagnostic procedure market. Gastrointestinal disorders encompass a range of illnesses affecting various sections of the digestive system and supporting organs, including the liver and pancreas. The gastric cancer diagnostic procedure is essential for addressing stomach cancer through methods such as endoscopy and biopsy. Therefore, the expanding incidence of gastrointestinal diseases is contributing to the market's growth. For instance, a study conducted by GI Associates & Endoscopy Center, a US-based medical facility specializing in gastroenterology services, involved 73,076 people from 33 nations, revealing that 40% of the subjects suffered from a functional gastrointestinal illness in August 2022. Hence, the increasing prevalence of gastrointestinal diseases is a significant factor propelling the growth of the gastric cancer diagnostic procedure market.

The rising prevalence of smoking is expected to drive the growth of the gastric cancer diagnostic procedure market in the future. Smoking involves the inhalation and exhalation of smoke produced by burning tobacco or other substances. Gastric cancer diagnostic procedures play a crucial role for individuals with a history of smoking or those at risk of smoking-related cancers by enabling early detection, identifying precancerous lesions, developing personalized treatment plans, facilitating communication and coordination, and providing a comprehensive assessment of the gastric mucosa and surrounding tissues. According to a report by The World Health Organization, a Switzerland-based intergovernmental organization, in July 2023, more than 8 million people are killed by tobacco each year, including 1.3 million non-smokers who inhale second-hand smoke. Therefore, the rising prevalence of smoking is a key driver of the growth of the gastric cancer diagnostic procedure market.

Technological advancements represent a prominent trend gaining momentum in the gastric cancer diagnostic market. Leading companies in the gastric cancer diagnostic market are actively incorporating new technologies to maintain their competitive positions. For example, in June 2022, Ibex Medical Analytics, an Israel-based provider of AI-powered diagnostics for health organizations, introduced Galen Gastric, the world's first AI-powered solution designed for gastric cancer detection. Galen Gastric serves as an integrated diagnostic tool assisting pathologists in identifying stomach cancer, H. pylori, and other critical clinical findings, contributing to faster turnaround times and improved diagnostic workflows.

Prominent companies in the gastric cancer diagnostic procedure market are strategically focusing on innovative products such as tissue staining platforms to drive revenue growth. The tissue staining platform aims to deliver rapid and precise test results, enabling medical professionals to make timely decisions regarding patient care. In June 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company, introduced the benchmark ultra plus system. This system, building on the proven technology of the benchmark ultra system, provides a fully automated workflow for immunohistochemistry (IHC) and in-situ hybridization (ISH) slide staining. It enhances the laboratory experience with features such as a retractable work surface, improved sliding drawers, indicator lights, and remote monitoring via a connected device, addressing user feedback. The system emphasizes efficient workflow, testing efficiency, and eco-friendly attributes.

In March 2023, Pfizer, a pharmaceutical corporation based in the United States, acquired Seagen Inc. for $43 billion. This acquisition strengthens Pfizer's position as a leading player in the oncology market by incorporating Seagen's groundbreaking antibody-drug conjugate (ADC) technology and expanding its portfolio of innovative cancer therapies. Seagen Inc. is a US-based biotechnology company focused on the discovery, development, and commercialization of transformative cancer medicines.

Major companies operating in the gastric cancer diagnostic procedure market include Pfizer Inc., Johnson & Johnson Co, F. Hoffmann La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories Inc., Sanofi SA, Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., AdventHealth, Atrium Health, Astellas Pharma Inc, Bausch Health Companies Inc., Agilent Technologies Inc., Ipsen Pharma, Hartford HealthCare, Myriad Genetics Inc., NovoCure Limited, Foundation Medicine Inc., Biocept Inc.

North America was the largest region in the gastric cancer diagnostics procedure market in 2024. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastric cancer diagnostic procedure market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastric cancer diagnostics procedure market includes revenues earned by entities that provide diagnostic procedures such as surgery, chemotherapy, and radiation therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastric Cancer Diagnostic Procedure Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastric cancer diagnostic procedure market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastric cancer diagnostic procedure ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastric cancer diagnostic procedure market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Procedure Type: Endoscopic Procedure; Biopsy; Tissue Tests; Lab Tests; In-Vitro Diagnostic Tests; Imaging Tests; Molecular Diagnostics; Multiplexing Molecular Diagnostics; Immunoassays; Other Procedure Types
2) By Symptom Type: Symptomatic; Asymptomatic
3) By Offering Type: Instruments; Reagents And Consumables; Services
4) By Body Fluid Type: Blood; Urine; Saliva; Stomach Juice; Tissue; Other Body Fluid
5) By Disease Indication: Early Gastric Cancer; Advanced Gastric Cancer
Subsegments:
1) By Endoscopic Procedure: Upper Endoscopy (EGD); Endoscopic Ultrasound (EUS)
2) By Biopsy: Endoscopic Biopsy; Fine Needle Aspiration (FNA) Biopsy
3) By Tissue Tests: Histopathology; Immunohistochemistry
4) By Lab Tests: Blood Tests; Tumor Markers
5) By In-Vitro Diagnostic Tests: Genetic Testing; Molecular Profiling
6) By Imaging Tests: Computed Tomography (CT) Scan; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scan
7) By Molecular Diagnostics: PCR Testing; Next-Generation Sequencing (NGS)
8) By Multiplexing Molecular Diagnostics: Multiplex PCR; Microarray Analysis
9) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA)
10) By Other Procedure Types: Breath Tests; Liquid Biopsies
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Co; F. Hoffmann La Roche Ltd.; Merck & Co. Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r24962

1. Executive Summary

2. Gastric Cancer Diagnostic Procedure Market Characteristics

3. Gastric Cancer Diagnostic Procedure Market Trends And Strategies

4. Gastric Cancer Diagnostic Procedure Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Gastric Cancer Diagnostic Procedure Growth Analysis And Strategic Analysis Framework

5.1. Global Gastric Cancer Diagnostic Procedure PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Gastric Cancer Diagnostic Procedure Market Growth Rate Analysis
5.4. Global Gastric Cancer Diagnostic Procedure Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Gastric Cancer Diagnostic Procedure Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Gastric Cancer Diagnostic Procedure Total Addressable Market (TAM)

6. Gastric Cancer Diagnostic Procedure Market Segmentation

6.1. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Endoscopic Procedure
Biopsy
Tissue Tests
Lab Tests
In-Vitro Diagnostic Tests
Imaging Tests
Molecular Diagnostics
Multiplexing Molecular Diagnostics
Immunoassays
Other Procedure Types
6.2. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Symptomatic
Asymptomatic
6.3. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instruments
Reagents and Consumables
Services
6.4. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Body Fluid Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood
Urine
Saliva
Stomach Juice
Tissue
Other Body Fluid
6.5. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Early Gastric Cancer
Advanced Gastric Cancer
6.6. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Endoscopic Procedure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Upper Endoscopy (EGD)
Endoscopic Ultrasound (EUS)
6.7. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Endoscopic Biopsy
Fine Needle Aspiration (FNA) Biopsy
6.8. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Tissue Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Histopathology
Immunohistochemistry
6.9. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Lab Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Tests
Tumor Markers
6.10. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of In-Vitro Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Testing
Molecular Profiling
6.11. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Computed Tomography (CT) Scan
Magnetic Resonance Imaging (MRI)
Positron Emission Tomography (PET) Scan
6.12. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Molecular Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PCR Testing
Next-Generation Sequencing (NGS)
6.13. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Multiplexing Molecular Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Multiplex PCR
Microarray Analysis
6.14. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Immunoassays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme-Linked Immunosorbent Assay (ELISA)
Radioimmunoassay (RIA)
6.15. Global Gastric Cancer Diagnostic Procedure Market, Sub-Segmentation Of Other Procedure Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Breath Tests
Liquid Biopsies

7. Gastric Cancer Diagnostic Procedure Market Regional And Country Analysis

7.1. Global Gastric Cancer Diagnostic Procedure Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Gastric Cancer Diagnostic Procedure Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastric Cancer Diagnostic Procedure Market

8.1. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastric Cancer Diagnostic Procedure Market

9.1. China Gastric Cancer Diagnostic Procedure Market Overview
9.2. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastric Cancer Diagnostic Procedure Market

10.1. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastric Cancer Diagnostic Procedure Market

11.1. Japan Gastric Cancer Diagnostic Procedure Market Overview
11.2. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastric Cancer Diagnostic Procedure Market

12.1. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastric Cancer Diagnostic Procedure Market

13.1. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastric Cancer Diagnostic Procedure Market

14.1. South Korea Gastric Cancer Diagnostic Procedure Market Overview
14.2. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastric Cancer Diagnostic Procedure Market

15.1. Western Europe Gastric Cancer Diagnostic Procedure Market Overview
15.2. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastric Cancer Diagnostic Procedure Market

16.1. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastric Cancer Diagnostic Procedure Market

17.1. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastric Cancer Diagnostic Procedure Market

18.1. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastric Cancer Diagnostic Procedure Market

19.1. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastric Cancer Diagnostic Procedure Market

20.1. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastric Cancer Diagnostic Procedure Market

21.1. Eastern Europe Gastric Cancer Diagnostic Procedure Market Overview
21.2. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastric Cancer Diagnostic Procedure Market

22.1. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastric Cancer Diagnostic Procedure Market

23.1. North America Gastric Cancer Diagnostic Procedure Market Overview
23.2. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastric Cancer Diagnostic Procedure Market

24.1. USA Gastric Cancer Diagnostic Procedure Market Overview
24.2. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastric Cancer Diagnostic Procedure Market

25.1. Canada Gastric Cancer Diagnostic Procedure Market Overview
25.2. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastric Cancer Diagnostic Procedure Market

26.1. South America Gastric Cancer Diagnostic Procedure Market Overview
26.2. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastric Cancer Diagnostic Procedure Market

27.1. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastric Cancer Diagnostic Procedure Market

28.1. Middle East Gastric Cancer Diagnostic Procedure Market Overview
28.2. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastric Cancer Diagnostic Procedure Market

29.1. Africa Gastric Cancer Diagnostic Procedure Market Overview
29.2. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastric Cancer Diagnostic Procedure Market Competitive Landscape And Company Profiles

30.1. Gastric Cancer Diagnostic Procedure Market Competitive Landscape
30.2. Gastric Cancer Diagnostic Procedure Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Co Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Gastric Cancer Diagnostic Procedure Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Bristol-Myers Squibb Company
31.3. Thermo Fisher Scientific Inc.
31.4. AstraZeneca plc
31.5. Abbott Laboratories Inc.
31.6. Sanofi SA
31.7. Eli Lilly and Company
31.8. Otsuka Pharmaceutical Co Ltd.
31.9. AdventHealth
31.10. Atrium Health
31.11. Astellas Pharma Inc
31.12. Bausch Health Companies Inc.
31.13. Agilent Technologies Inc.
31.14. Ipsen Pharma
31.15. Hartford HealthCare

32. Global Gastric Cancer Diagnostic Procedure Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastric Cancer Diagnostic Procedure Market

34. Recent Developments In The Gastric Cancer Diagnostic Procedure Market

35. Gastric Cancer Diagnostic Procedure Market High Potential Countries, Segments and Strategies

35.1 Gastric Cancer Diagnostic Procedure Market In 2029 - Countries Offering Most New Opportunities
35.2 Gastric Cancer Diagnostic Procedure Market In 2029 - Segments Offering Most New Opportunities
35.3 Gastric Cancer Diagnostic Procedure Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer